Welcome to our dedicated page for Shoulder Innovations news (Ticker: SI), a resource for investors and traders seeking the latest updates and insights on Shoulder Innovations stock.
News about Shoulder Innovations, Inc. (NYSE: SI) focuses on its activities as a commercial-stage medical technology company dedicated to the shoulder surgical care market. Company announcements frequently highlight developments in advanced implant systems for shoulder arthroplasty, enabling technologies and the broader ecosystem that supports surgeons and patients.
Readers of this news feed can expect updates on quarterly and periodic financial results, where Shoulder Innovations reports metrics such as net revenue, gross margin, operating loss and the number of implant systems sold. These releases often include discussion of business momentum, investments in research and development and the company’s use of non-GAAP measures like Adjusted EBITDA.
The news flow also covers product and portfolio developments. For example, the company has announced the full commercial launch of the InSet 70 humeral stem as an expansion of its I-Series humeral stem product line for shoulder arthroplasty. Such announcements describe clinical indications, workflow characteristics and how new offerings fit within the company’s broader shoulder arthroplasty portfolio.
Strategic and corporate events appear regularly as well, including participation in healthcare conferences, initial public offering and financing updates and partnerships. A notable example is the strategic partnership with Interventional Systems to develop a shoulder-specific micro-robotic solution intended to integrate with the ProVoyance platform and enhance surgical precision and workflow.
By following news linked to the SI ticker, investors and observers can review company-issued information on financial performance, product launches, strategic collaborations and conference participation, all centered on Shoulder Innovations’ exclusive focus on the shoulder surgical care market.
Shoulder Innovations (NYSE: SI) appointed medtech executive Drew Hykes to its Board of Directors and Compensation Committee, effective February 26, 2026, while Geoff Pardo resigned as an independent director. Hykes brings 25+ years of device experience, including leadership roles at Okami Medical, Inari Medical, and Medtronic.
Management changes signal governance refresh as Shoulder Innovations scales commercial adoption of its shoulder arthroplasty portfolio.
Shoulder Innovations (NYSE: SI) said management will present at the Canaccord Genuity 2026 Musculoskeletal Conference on Tuesday, March 3, 2026 at 2:00 p.m. CT / 12:00 p.m. PT.
According to the company, a live webcast and archived replay will be available via the Investor Relations section of its website.
Shoulder Innovations (NYSE: SI) will release fourth quarter and full year 2025 financial results after market close on March 10, 2026. Management will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT on March 10, 2026 to discuss results.
Dial-in numbers are (877) 407-8216 (U.S.) or (412) 902-1015 (international) with access code 13758375. A live and archived webcast will be available in the Investor Relations section at https://ir.shoulderinnovations.com/.
Shoulder Innovations (NYSE: SI) said management will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, UT on February 10–11, 2026. The presentation offers an investor update and engagement with industry attendees and analysts.
Shoulder Innovations (NYSE: SI) announced on December 3, 2025 a strategic partnership with Interventional Systems (INS) to develop a shoulder-specific micro-robotic platform that will integrate with Shoulder Innovations' ProVoyance system.
The portable robot is designed for transport directly into the operating room and aims to improve surgical precision, workflow efficiency, and enable new clinical approaches in total and reverse shoulder arthroplasty, with a stated focus on ambulatory surgery centers (ASCs). The companies said the solution targets high implementation costs, mobility limits, perioperative inefficiencies, and steep learning curves associated with existing robotic systems.
Shoulder Innovations (NYSE: SI) said members of management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 8:30 a.m. ET / 5:30 a.m. PT. The event is scheduled as a live session with an archived webcast available after the presentation.
Investors can access the live and archived presentation on the company’s InvestorRelations website at https://ir.shoulderinnovations.com/.
Shoulder Innovations (NYSE: SI) announced the full commercial launch of the InSet™ 70 humeral stem on Sept. 22, 2025 in Grand Rapids, Mich.
The InSet™ 70 expands the company’s I-Series humeral stem line (which began with the InSet™ 95 in 2024), is cleared for both anatomic and reverse shoulder arthroplasty, and addresses indications including osteoarthritis, avascular necrosis, rheumatoid and traumatic arthritis, irreparable cuff tears, and certain revision cases.
Company statements highlight the InSet™ 70’s bone-sparing design, initial fixation comparable to the longer InSet™ 95, simplified surgical workflow, and claimed optimized biomechanics intended to support improved shoulder function for patients.
Shoulder Innovations (NYSE: SI) reported third-quarter 2025 results on Nov 11, 2025, with Q3 revenue of $11.8M, up 58% year-over-year, and 1,584 implant systems sold (up 53%). Gross margin was 76.2%. SG&A rose 78% to $15.1M and R&D rose 40% to $1.5M, producing an operating loss of $7.6M and net loss of $8.7M. Adjusted EBITDA loss was $7.5M. Cash and marketable securities totaled $137M, reflecting ~$115M of IPO and convertible note proceeds. The company raised full‑year 2025 revenue guidance to $45–46M (growth ~42–45% vs 2024).
Shoulder Innovations (NYSE: SI) announced that CEO Rob Ball will present at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025.
Presentation time: 8:30 a.m. GMT / 3:30 a.m. EST. A live and archived version of the fireside chat will be available on the company’s Investor Relations website at https://ir.shoulderinnovations.com/.
Shoulder Innovations (NYSE: SI) will release third quarter 2025 financial results after market close on November 11, 2025. Management will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT the same day to discuss results.
Investors can join by phone using domestic dial-in (877) 407-8216, international dial-in (412) 902-1015 and access code 13756311. A live and archived webcast will be available in the Investor Relations section at https://ir.shoulderinnovations.com/.